04/18/2017 - 2:27pm

The recall includes all products that retailers may have had in stock since Standard Homeopathic stopped making and shipping the medicines nationwide in October 2016.

04/14/2017 - 2:58pm

This could be the year. Movement again is occurring in Congress on legislation that would confer professional provider status on pharmacists serving millions of older Americans in many parts of the country.

04/14/2017 - 2:56pm

Legislation pending in both houses of Congress regarding DIR, or direct and indirect remuneration, fees are giving hope to drug stores and two of the industry’s largest advocacy groups that pharmacy benefits management companies will stop retroactively reducing payments.

04/14/2017 - 2:54pm

Although 2016 saw the Food and Drug Administration approve only 22 new drugs compared with 45 approvals in 2015 and the lowest tally since 2010, many in the pharmaceutical arena remain optimistic that this year will see a reversal of that trend.

04/14/2017 - 2:51pm

State senators voted 22-9 in favor of approving a measure intended to help ease the state’s growing opioid epidemic.

04/14/2017 - 2:11pm

The Canadian Pharmacists Association on Thursday expressed its concern over pharmacists being left out of recently introduced legislation tweaking the country’s marijuana laws to legalize recreational pot while preserving a separate stream for medical marijuana. 

04/14/2017 - 11:37am
The National Retail Federation has launched the next phase of a television and digital ad campaign against the tax, which is included in the House Republican tax reform plan.
04/07/2017 - 2:53pm

Retired Four-Star Marine Gen. John Allen, speak at the Business Program on Sunday, April 23, while Richard W. Fisher, who served as president and CEO of the Federal Reserve Bank of Dallas from 2005 to 2015, will speak at the Business Program on Tuesday, April 25.
 

04/06/2017 - 2:03pm

The National Community Pharmacists Association is backing legislation that it says would improve pharmacy access for seniors with Medicare Part D drug plans.